<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Helix Biopharma Corp. — News on 6ix</title>
<link>https://6ix.com/company/helix-biopharma-corp</link>
<description>Latest news and press releases for Helix Biopharma Corp. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 16 Mar 2026 21:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/helix-biopharma-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835fa4b78dffbe2df1313d8.webp</url>
<title>Helix Biopharma Corp.</title>
<link>https://6ix.com/company/helix-biopharma-corp</link>
</image>
<item>
<title>Helix BioPharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-financial-results-and-filing-of-interim-financial-statements-as-of-and-for-the-three-and-six-month-periods-ended-january-31-2026</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-financial-results-and-filing-of-interim-financial-statements-as-of-and-for-the-three-and-six-month-periods-ended-january-31-2026</guid>
<pubDate>Mon, 16 Mar 2026 21:00:00 GMT</pubDate>
<description>(TheNewswire) &#xA0; Toronto, Ontario &#x2013; TheNewswire - 16 March, 2026 &#x2013; Heli...</description>
</item>
<item>
<title>Helix BioPharma Corp. Announces Presentation at 16th Annual World ADC London</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-presentation-at-16th-annual-world-adc-london</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-presentation-at-16th-annual-world-adc-london</guid>
<pubDate>Tue, 24 Feb 2026 14:29:15 GMT</pubDate>
<description>TORONTO, ONTARIO - February 24, 2026 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are...</description>
</item>
<item>
<title>Helix Biopharma Corp. Extends LEUMUNA Option With metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-extends-leumuna-213000215</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-extends-leumuna-213000215</guid>
<pubDate>Thu, 05 Feb 2026 21:30:00 GMT</pubDate>
<description>TORONTO, ONTARIO - February 5, 2026 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are ...</description>
</item>
<item>
<title>Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-extends-leumuna-option-with-metashape-pharma-for-adipose-tissue-related-and-metabolic-diseases</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-extends-leumuna-option-with-metashape-pharma-for-adipose-tissue-related-and-metabolic-diseases</guid>
<pubDate>Thu, 05 Feb 2026 21:30:00 GMT</pubDate>
<description>(TheNewswire) (Toronto, Ontario; February 5, 2026) &#x2013; TheNewswire - Helix BioPharma...</description>
</item>
<item>
<title>Helix BioPharma Corp. Announces Voting Results From Its Annual General and Special Meeting</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-voting-213000893</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-voting-213000893</guid>
<pubDate>Fri, 30 Jan 2026 21:30:00 GMT</pubDate>
<description>TORONTO, ONTARIO - January 30, 2026 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: "HBP", OTC: "HBPCF", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are vinci...</description>
</item>
<item>
<title>Helix BioPharma Corp. Announces Voting Results from its Annual General and Special Meeting</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-voting-results-from-its-annual-general-and-special-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-voting-results-from-its-annual-general-and-special-meeting</guid>
<pubDate>Fri, 30 Jan 2026 21:30:00 GMT</pubDate>
<description>(TheNewswire) &#xA0; Toronto, Ontario &#x2013; TheNewswire - 30 January, 2026 &#x2013; ...</description>
</item>
<item>
<title>Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-filing-of-interim-financial-statements-as-of-and-for-the-three-month-period-ended-october-31-2025</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-filing-of-interim-financial-statements-as-of-and-for-the-three-month-period-ended-october-31-2025</guid>
<pubDate>Mon, 15 Dec 2025 22:30:00 GMT</pubDate>
<description>(TheNewswire) Toronto, Ontario &#x2013; TheNewswire - 15 December, 2025 &#x2013; He...</description>
</item>
<item>
<title>Helix BioPharma Corp. Announces Fiscal 2025 Year-End Results</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-fiscal-2025-year-end-results</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-fiscal-2025-year-end-results</guid>
<pubDate>Wed, 29 Oct 2025 16:45:00 GMT</pubDate>
<description>(TheNewswire) Toronto, Ontario &#x2013; TheNewswire - 29 October 2025 &#x2013; ...</description>
</item>
<item>
<title>Helix BioPharma Responds to Market Activity</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-responds-to-market-activity</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-responds-to-market-activity</guid>
<pubDate>Mon, 06 Oct 2025 15:35:00 GMT</pubDate>
<description>(TheNewswire) Toronto, Ontario &#x2013; TheNewswire - 6 October 2025 &#x2013; H...</description>
</item>
<item>
<title>Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-announces-presentation-at-q3-investor-summit-virtual-on-16-september-2025</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-announces-presentation-at-q3-investor-summit-virtual-on-16-september-2025</guid>
<pubDate>Tue, 09 Sep 2025 20:15:00 GMT</pubDate>
<description>(TheNewswire) Toronto, Ontario &#x2013; TheNewswire - 9 September 2025 &#x2013;...</description>
</item>
<item>
<title>Helix BioPharma Concludes Review, Will Not Proceed with Proposed Equity Draw-Down Subscription Facility with GEM</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-concludes-review-will-not-proceed-with-proposed-equity-draw-down-subscription-facility-with-gem</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-concludes-review-will-not-proceed-with-proposed-equity-draw-down-subscription-facility-with-gem</guid>
<pubDate>Fri, 05 Sep 2025 20:15:00 GMT</pubDate>
<description>(TheNewswire) Toronto, Ontario &#x2013; TheNewswire - 5 September 2025 &#x2013;...</description>
</item>
<item>
<title>Helix BioPharma Concludes Review, Will Not Proceed With Proposed Equity Draw-Down Subscription Facility With GEM</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-concludes-review-not-201500028</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-concludes-review-not-201500028</guid>
<pubDate>Fri, 05 Sep 2025 20:15:00 GMT</pubDate>
<description>TORONTO, ONTARIO - September 5, 2025 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: "HBP", OTC: "HBPCF", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are vinc...</description>
</item>
<item>
<title>Helix Biopharma Corp. Announces Closing of Private Placement, in Preparation for Institutional Investment and NASDAQ Uplisting</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-closing-of-private-placement-in-preparation-for-institutional-investment-and-nasdaq-uplisting</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-closing-of-private-placement-in-preparation-for-institutional-investment-and-nasdaq-uplisting</guid>
<pubDate>Fri, 22 Aug 2025 22:00:00 GMT</pubDate>
<description>(TheNewswire) Toronto, Ontario (22 August 2025) &#x2013; TheNewswire - Helix Bi...</description>
</item>
<item>
<title>Helix Biopharma Corp. Announces Publication in Frontiers in Oncology on the Effects of L-DOS47 as Monotherapy in NSCLC</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-publication-in-frontiers-in-oncology-on-the-effects-of-l-dos47-as-monotherapy-in-nsclc</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-publication-in-frontiers-in-oncology-on-the-effects-of-l-dos47-as-monotherapy-in-nsclc</guid>
<pubDate>Wed, 13 Aug 2025 15:10:00 GMT</pubDate>
<description>(TheNewswire) Toronto, Ontario &#x2013; TheNewswire - 13 August 2025 &#x2013; ...</description>
</item>
<item>
<title>Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Nine Month Period Ended April 30, 2025</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-filing-of-interim-financial-statements-as-of-and-for-the-nine-month-period-ended-april-30-2025</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-filing-of-interim-financial-statements-as-of-and-for-the-nine-month-period-ended-april-30-2025</guid>
<pubDate>Mon, 16 Jun 2025 23:00:00 GMT</pubDate>
<description>(TheNewswire) (Toronto, Ontario) &#x2013; Helix BioPharma Corp. - TheNewswire - (TS...</description>
</item>
<item>
<title>Helix BioPharma Corp. Announces CFO Appointment to Support Strategic Growth and Upcoming Milestones</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-cfo-appointment-to-support-strategic-growth-and-upcoming-milestones</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-announces-cfo-appointment-to-support-strategic-growth-and-upcoming-milestones</guid>
<pubDate>Mon, 02 Jun 2025 20:30:00 GMT</pubDate>
<description>(TheNewswire) 2 June 2025 &#x2013; TheNewswire - (Toronto, Ontario) &#x2013; ...</description>
</item>
<item>
<title>Helix BioPharma (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") Secures Pre-IND Candidates LEUMUNA(TM) and GEMCEDA(TM) in Strategic Acquisition from the Laevoroc Group</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-tsx-hbp-otc-pink-hbpcd-frankfurt-hbp0-secures-pre-ind-candidates-leumunatm-and-gemcedatm-in-strategic-acquisition-from-the-laevoroc-group</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-tsx-hbp-otc-pink-hbpcd-frankfurt-hbp0-secures-pre-ind-candidates-leumunatm-and-gemcedatm-in-strategic-acquisition-from-the-laevoroc-group</guid>
<pubDate>Tue, 20 May 2025 13:00:00 GMT</pubDate>
<description>(TheNewswire) May 20 , 2025 &#x2013; TheNewswire - Toronto, Ontario ...</description>
</item>
<item>
<title>Helix BioPharma Corp. (HBP.TO) Signs Capital Raising Agreement with Kerentech Consulting Ltd.</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-hbpto-signs-capital-raising-agreement-with-kerentech-consulting-ltd</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-hbpto-signs-capital-raising-agreement-with-kerentech-consulting-ltd</guid>
<pubDate>Wed, 14 May 2025 15:45:00 GMT</pubDate>
<description>(TheNewswire) May 14, 2025 &#x2013; TheNewswire - Toronto, Ontario &#x2013; ...</description>
</item>
<item>
<title>Helix BioPharma Corp. Appoints New COO and Communications Director to Accelerate Growth and Deliver on its Mission Against Hard-to-Treat Cancers</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-appoints-new-coo-and-communications-director-to-accelerate-growth-and-deliver-on-its-mission-against-hard-to-treat-cancers</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-appoints-new-coo-and-communications-director-to-accelerate-growth-and-deliver-on-its-mission-against-hard-to-treat-cancers</guid>
<pubDate>Thu, 24 Apr 2025 15:15:00 GMT</pubDate>
<description>(TheNewswire) Toronto, Ontario &#x2013; TheNewswire &#x2013; April 24, 2025 - Helix...</description>
</item>
<item>
<title>Helix BioPharma Corp. Appoints Dr. Thomas Mehrling as Chief Executive Officer to Drive Ambitious Clinical Development Plan</title>
<link>https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-appoints-dr-thomas-mehrling-as-chief-executive-officer-to-drive-ambitious-clinical-development-plan</link>
<guid isPermaLink="true">https://6ix.com/company/helix-biopharma-corp/news/helix-biopharma-corp-appoints-dr-thomas-mehrling-as-chief-executive-officer-to-drive-ambitious-clinical-development-plan</guid>
<pubDate>Thu, 10 Apr 2025 15:30:00 GMT</pubDate>
<description>(TheNewswire) April 10, 2025 &#x2013; TheNewswire - Toronto, Ontario &#x2013; Helix...</description>
</item>
</channel>
</rss>